NCT00697216 Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs). Status COMPLETED Phase PHASE3
NCT00697125 Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants Status COMPLETED Phase PHASE2
NCT00696917 Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y Status COMPLETED Phase PHASE3
NCT00696891 Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults Status COMPLETED Phase PHASE3
NCT00693186 A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA Status COMPLETED Phase PHASE3
NCT00684671 Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination Status COMPLETED Phase PHASE4
NCT00674908 Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine Status COMPLETED Phase PHASE4
NCT00670839 Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST) Status COMPLETED Phase PHASE3
NCT00662545 Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection Status COMPLETED Phase PHASE4
NCT00657657 Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine Status COMPLETED Phase PHASE4
NCT00654901 Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ Status COMPLETED Phase PHASE3
NCT00645294 Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV Status COMPLETED Phase PHASE1/PHASE2
NCT00644761 PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients Status COMPLETED Phase PHASE2
NCT00629486 Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma Status COMPLETED Phase NA
NCT00627458 Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine Status COMPLETED Phase PHASE2
NCT00619502 Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants Status COMPLETED Phase PHASE3
NCT00617812 Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine Status COMPLETED Phase PHASE4
NCT00611559 Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children Status COMPLETED Phase PHASE4
NCT00603252 Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults Status COMPLETED Phase PHASE4
NCT00562783 A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis Status COMPLETED Phase PHASE2